Psychiatry and Neurology, Neurology · Hopewell, NJ
NPI
1851548671
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
45 E Broad St
Hopewell, NJ, 08525
Phone (609) 466-0121
Groups this clinician bills Medicare through
Medicare paid, 2023
$138K
16,950 services
Medicare patients, 2023
287
Average age 74
Drug cost, 2024
$1.5M
2,052 prescriptions
Company payments, 2025
$254K
From 10 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Jill M Giordano Farmer was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,000 times for 23 patients. In total Jill M Giordano Farmer billed 16,950 services in 22 codes, and Medicare paid $138K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,000 | 23 | $4.83 | $43K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 6,700 | 20 | $4.06 | $27K |
| 99214 Office E&M - Established | Office | 355 | 202 | $94.26 | $33K |
| 99205 Office E&M - New | Office | 44 | 44 | $178.57 | $7,857 |
| 99213 Office E&M - Established | Office | 43 | 25 | $65.62 | $2,822 |
| 64642 Musculoskeletal | Office | 29 | 19 | $129.68 | $3,761 |
| 64616 Musculoskeletal | Office | 21 | 12 | $158.91 | $3,337 |
| 64643 Musculoskeletal | Office | 17 | 12 | $79.23 | $1,347 |
| 99215 Office E&M - Established | Office | 16 | 11 | $133.55 | $2,137 |
By year: 2022 $169K for 20,089 services; 2023 $138K for 16,950 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jill M Giordano Farmer prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 466 prescriptions and refills. In total Jill M Giordano Farmer wrote 2,052 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 466 | 1,174 | 176 | $24K |
| Rasagiline Mesylate Generic | 158 | 402 | 51 | $38K |
| Nuplazid Pimavanserin Tartrate | 116 | 130 | 15 | $644K |
| Clonazepam Generic | 98 | 184 | 37 | $1,285 |
| Rivastigmine Rivastigmine Tartrate | 62 | 158 | 26 | $4,128 |
| Nourianz Istradefylline | 62 | 101 | 14 | $200K |
| Rytary Carbidopa/Levodopa | 57 | 137 | 15 | $73K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 57 | 146 | 19 | $5,549 |
| Escitalopram Oxalate Generic | 53 | 105 | 17 | $544 |
| Quetiapine Fumarate Generic | 50 | 113 | 17 | $872 |
| Amantadine Amantadine Hcl | 48 | 114 | 17 | $2,488 |
| Gocovri Amantadine Hcl | 47 | 59 | Under 11 | $125K |
| Selegiline Hcl Generic | 39 | 93 | 12 | $5,476 |
| Alprazolam Generic | 38 | 48 | 17 | $185 |
| Sertraline Hcl Generic | 37 | 69 | 13 | $591 |
Brand drugs: 469 claims; generic drugs: 1,583 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jill M Giordano Farmer $254K ($254K in general payments such as food, travel and fees) from 10 companies. The largest payer was Amneal Pharmaceuticals LLC with $72K.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 52 | $72K |
| Neurocrine BioSciences, Inc. NBIX | 37 | $61K |
| ACADIA Pharmaceuticals Inc ACAD | 37 | $44K |
| MDD US Operations, LLC | 40 | $26K |
| Teva Pharmaceuticals USA, Inc. TEVA | 26 | $26K |
| Abbvie Inc. ABBV | 19 | $19K |
| Kyowa Kirin, Inc. 4151.T | 1 | $5,250 |
| Ge Healthcare GEHC | 1 | $92.82 |
| Boston Scientific Corporation BSX | 1 | $88.22 |
| Revance Therapeutics, Inc. | 1 | $36.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.